151 related articles for article (PubMed ID: 28774123)
1. Floating Hydrogel with Self-Generating Micro-Bubbles for Intravesical Instillation.
Lin T; Zhao X; Zhang Y; Lian H; Zhuang J; Zhang Q; Chen W; Wang W; Liu G; Guo S; Wu J; Hu Y; Guo H
Materials (Basel); 2016 Dec; 9(12):. PubMed ID: 28774123
[TBL] [Abstract][Full Text] [Related]
2. A floating hydrogel system capable of generating CO2 bubbles to diminish urinary obstruction after intravesical instillation.
Lin T; Zhang Y; Wu J; Zhao X; Lian H; Wang W; Guo H; Hu Y
Pharm Res; 2014 Oct; 31(10):2655-63. PubMed ID: 24752478
[TBL] [Abstract][Full Text] [Related]
3. Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release.
Zhu G; Zhang Y; Wang K; Zhao X; Lian H; Wang W; Wang H; Wu J; Hu Y; Guo H
Drug Deliv; 2016 Oct; 23(8):2820-2826. PubMed ID: 26515239
[TBL] [Abstract][Full Text] [Related]
4. In situ floating hydrogel for intravesical delivery of adriamycin without blocking urinary tract.
Lin T; Wu J; Zhao X; Lian H; Yuan A; Tang X; Zhao S; Guo H; Hu Y
J Pharm Sci; 2014 Mar; 103(3):927-36. PubMed ID: 24449076
[TBL] [Abstract][Full Text] [Related]
5. Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.
Yoon HY; Chang IH; Goo YT; Kim CH; Kang TH; Kim SY; Lee SJ; Song SH; Whang YM; Choi YW
Int J Nanomedicine; 2019; 14():6249-6268. PubMed ID: 31496684
[TBL] [Abstract][Full Text] [Related]
6. Sustained intravesical drug delivery using thermosensitive hydrogel.
Tyagi P; Li Z; Chancellor M; De Groat WC; Yoshimura N; Huang L
Pharm Res; 2004 May; 21(5):832-7. PubMed ID: 15180342
[TBL] [Abstract][Full Text] [Related]
7. Optimization of a floating poloxamer 407-based hydrogel using the Box-Behnken design: in vitro characterization and in vivo buoyancy evaluation for intravesical instillation.
Goo YT; Yang HM; Kim CH; Kim MS; Kim HK; Chang IH; Choi YW
Eur J Pharm Sci; 2021 Aug; 163():105885. PubMed ID: 34022408
[TBL] [Abstract][Full Text] [Related]
8. Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer.
Yoon HY; Yang HM; Kim CH; Goo YT; Kang MJ; Lee S; Choi YW
Expert Opin Drug Deliv; 2020 Nov; 17(11):1555-1572. PubMed ID: 32791923
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Retention Microbubbles with Three-Layer Structure for Floating Intravesical Instillation Delivery.
Deng Q; Xie J; Kong S; Tang T; Zhou J
Small; 2023 Apr; 19(14):e2205630. PubMed ID: 36634975
[TBL] [Abstract][Full Text] [Related]
10. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
11. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K
Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733
[TBL] [Abstract][Full Text] [Related]
12. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.
Men K; Liu W; Li L; Duan X; Wang P; Gou M; Wei X; Gao X; Wang B; Du Y; Huang M; Chen L; Qian Z; Wei Y
Nanoscale; 2012 Oct; 4(20):6425-33. PubMed ID: 22955255
[TBL] [Abstract][Full Text] [Related]
13. Re: A Floating Hydrogel System Capable of Generating CO2 Bubbles to Diminish Urinary Obstruction after Intravesical Instillation.
Chang SS
J Urol; 2016 Feb; 195(2):525-6. PubMed ID: 26853038
[No Abstract] [Full Text] [Related]
14. Intravesical instillation of onabotulinum toxin A embedded in inert hydrogel in the treatment of idiopathic overactive bladder: A double-blind randomized pilot study.
Krhut J; Navratilova M; Sykora R; Jurakova M; Gärtner M; Mika D; Pavliska L; Zvara P
Scand J Urol; 2016 Jun; 50(3):200-5. PubMed ID: 27111192
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome: Systematic Review and Meta-analysis.
Lee HY; Doo SW; Yang WJ; Song YS; Sun HY; Nho EJ; Lee B; Kim JH
Urology; 2019 Mar; 125():50-57. PubMed ID: 30552935
[TBL] [Abstract][Full Text] [Related]
16. A Hydrogel-Based Epirubicin Delivery System for Intravesical Chemotherapy.
Liu CW; Wu YT; Lin KJ; Yu TJ; Kuo YL; Chang LC
Molecules; 2016 Jun; 21(6):. PubMed ID: 27258243
[TBL] [Abstract][Full Text] [Related]
17. A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette-Guérin in the treatment of bladder cancer.
Zhang D; Sun P; Li P; Xue A; Zhang X; Zhang H; Jin X
Biomaterials; 2013 Dec; 34(38):10258-66. PubMed ID: 24070571
[TBL] [Abstract][Full Text] [Related]
18. Intravesical drug delivery for dysfunctional bladder.
Hsu CC; Chuang YC; Chancellor MB
Int J Urol; 2013 Jun; 20(6):552-62. PubMed ID: 23336527
[TBL] [Abstract][Full Text] [Related]
19. Intravesical treatments for painful bladder syndrome/ interstitial cystitis.
Dawson TE; Jamison J
Cochrane Database Syst Rev; 2007 Oct; (4):CD006113. PubMed ID: 17943887
[TBL] [Abstract][Full Text] [Related]
20. Novel Therapy with Intravesical Liposomes for Ulcerative Interstitial Cystitis/Painful Bladder Syndrome.
Peters KM; Hasenau DL; Anthony M; Kaufman J; Killinger KA
Low Urin Tract Symptoms; 2012 Jan; 4(1):51-3. PubMed ID: 26676460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
